Use of proton pump inhibitors is associated with lower rates of first-time ischemic stroke in community-dwelling elderly.

British Journal of Clinical Pharmacology
Hemda Schmilovitz-WeissAvraham Weiss

Abstract

Data on cardiovascular outcomes in elderly using proton pump inhibitors (PPI) are scant. We aimed to test the association between PPI use and the occurrence of first-time ischemic stroke (FTIS) among elderly. The electronic database of a centrally located district branch of a large health maintenance organization in Israel was retrospectively screened (2002-2016) for community-dwelling individuals (≥65-95 years) for demographics and co-morbidities. Follow-up was until FTIS, death or end of study. Findings were analyzed by PPI use and occurrence of FTIS. 29,639 subjects (without history of stroke and use of antiplatelet aggregation drugs) mean age of 82.2 ± 5.5 years (range: 65-95 years, 38% male) were analyzed: 8,600 (29%) used PPIs. Mean follow up was 10.58 years (SD ± 5.44). Similar total and annual occurrence rates of FTIS were depicted in PPI users and non-users (20.9% vs. 21% and 2% vs. 2.1%, respectively). On a Cox regression analysis, upon adjustment for age, gender and cardiovascular disease related risk factors, PPI use was significantly associated with lower rates of FTIS (HR 0.73, 95% C.I. 0.69-0.77, p < 0.001). The risk for FTIS was significantly lower in subjects using PPI at any dose and for any time period compar...Continue Reading

References

Jul 27, 2005·Alimentary Pharmacology & Therapeutics·A S RaghunathR C McLoughlin
Jan 15, 2008·Atherosclerosis·Yuri Sheikine, Allan Sirsjö
Feb 7, 2015·Stroke; a Journal of Cerebral Circulation·Charles E LeonardSean Hennessy
Nov 4, 2015·JAMA : the Journal of the American Medical Association·Elizabeth D KantorEdward L Giovannucci
Dec 30, 2015·The American Journal of Medicine·Alon GrossmanJoseph Meyerovitch
Aug 23, 2016·Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association·Xingyang YiLifen Chi
Sep 7, 2016·European Journal of Internal Medicine·Alon GrossmanAvraham Weiss
Jan 29, 2017·Current Treatment Options in Gastroenterology·Felice Schnoll-Sussman, Philip O Katz
Mar 23, 2017·International Heart Journal·Wengen Zhu, Kui Hong
Jan 18, 2018·Stroke; a Journal of Cerebral Circulation·Konark MalhotraGeorgios Tsivgoulis
Mar 31, 2018·Minerva gastroenterologica e dietologica·Rinaldo PellicanoSteven F Moss
Jun 20, 2018·Stroke; a Journal of Cerebral Circulation·K S Lawrence WongUNKNOWN SOCRATES Steering Committee and Investigators
Jul 27, 2018·European Journal of Gastroenterology & Hepatology·Hemda Schmilovitz-WeissAvraham Weiss
Aug 10, 2018·Gastroenterology·Cong DaiMing-Jun Sun
Aug 22, 2018·Journal of Neurology·Georgios TsivgoulisKonstantinos Vadikolias
Aug 30, 2018·Curēus·Saad Saleem, Abell L Thomas
Sep 12, 2018·Helicobacter·Olga SjominaMarcis Leja
Nov 22, 2019·European Journal of Clinical Pharmacology·Yun ZhangYehuan Sun
Dec 1, 2019·Atherosclerosis·Juan F Sánchez Muñoz-TorreroUNKNOWN FRENA Investigators

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aging-Associated Metabolic Disorders

Age is associated with many metabolic disorders including cardiovascular diseases, type 2 diabetes, stroke and heart disease. The mediators in aging process have been suggested to play a part in the cellular processes responsible for these metabolic disorders. Here is the latest research on aging-associated metabolic disorders.

© 2021 Meta ULC. All rights reserved